DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION

Bibliographic Details
Main Authors:	Xue, D, Huang, Z, Smith, K, Lesiuk, H, Buchan, A
Format:	Journal article
Published:	1992

Similar Items

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
by: Xue, D, et al.
Published: (1994)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
by: Li, H, et al.
Published: (1992)

Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
by: Buchan, A, et al.
Published: (1991)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
by: Buchan, A, et al.
Published: (1993)

MK-801 REDUCES THE VOLUME OF NEOCORTICAL INFARCTION BUT ALSO INCREASES REGIONAL CEREBRAL BLOOD-FLOW
by: Buchan, A, et al.
Published: (1990)

NMDA antagonists: their role in neuroprotection.
by: Small, D, et al.
Published: (1997)

NMDA antagonists: their role in neuroprotection.
by: Small, D, et al.
Published: (1997)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
by: Buchan, A, et al.
Published: (1992)

Do NMDA antagonists prevent neuronal injury? No.
by: Buchan, A
Published: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
by: Hoyte, L, et al.
Published: (2004)

Immediate or delayed mild hypothermia prevents focal cerebral infarction.
by: Xue, D, et al.
Published: (1992)

U74006F REDUCES NEOCORTICAL INFARCTION BUT DOES NOT ATTENUATE SELECTIVE HIPPOCAMPAL CA1 NECROSIS
by: Dong, X, et al.
Published: (1990)

Modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and α-tocopherol in glutamate- induced injury of primary astrocytes
by: Abedi, Zahra
Published: (2017)

The modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and A-tocopherol in glutamate-induced injury of primary astrocytes
by: Abedi, Zahra, et al.
Published: (2017)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
by: Hicks, C, et al.
Published: (1999)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
by: Buchan, A
Published: (1990)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
by: Murray, R, et al.
Published: (1995)

CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
by: Menniti, F, et al.
Published: (2003)

Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
by: Li, H, et al.
Published: (1993)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
by: Buchan, A, et al.
Published: (1992)

A new model of temporary focal neocortical ischemia in the rat.
by: Buchan, A, et al.
Published: (1992)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
by: Iversen, S, et al.
Published: (1987)

A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia.
by: Buchan, A, et al.
Published: (1994)

The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats.
by: Tonkiss, J, et al.
Published: (1991)

NMDA receptor antagonists can enhance or impair learning performance in animals.
by: Mondadori, C, et al.
Published: (1989)

NMDA-receptor antagonists disrupt the formation of the auditory space map in the mammalian superior colliculus.
by: Schnupp, J, et al.
Published: (1995)

Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys.
by: Gutnikov, SA, et al.
Published: (1996)

Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.
by: Pulsinelli, W, et al.
Published: (1993)

Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain.
by: Hudspith, M, et al.
Published: (1999)

Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain.
by: Munglani, R, et al.
Published: (1999)

Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
by: Xue, D, et al.
Published: (1992)

Delayed maturation of cortical infarction: Role of caspases and NF-kappa B-mediated transcription
by: Buchan, A
Published: (2001)

The Wanderlust of Newborn Neocortical Interneurons
by: Sanjana, Neville E., et al.
Published: (2010)

Plasticity in development of neocortical areas - Discussion
by: Daw, N, et al.
Published: (1995)

DETERMINATION OF THE POTENCIES OF THE R-(+) AND S-(-) ENANTIOMERS OF HA-966 AS ANTAGONISTS OF THE GLYCINE SITE ON THE NMDA RECEPTOR COMPLEX
by: Kemp, J, et al.
Published: (1990)

Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
by: Buchan, A, et al.
Published: (1994)

Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors.
by: Harrison, P, et al.
Published: (2006)

Do caspase and proteasome inhibitors influence the delayed maturation of cortical infarction by preventing apoptosis or neuroinflammation?
by: Buchan, A
Published: (2000)

MODERATE HYPOTHERMIA PREVENTS FOCAL INFARCTION
by: Xue, D, et al.
Published: (1991)

Reinforcement-Related Regulation of AMPA Glutamate Receptor Subunits in the Ventral Tegmental Area Enhances Motivation for Cocaine
by: Choi, Kwang Ho, et al.
Published: (2012)